Effects of a probiotic fermented milk beverage containing Lactobacillus casei strain Shirota on defecation frequency, intestinal microbiota, and the intestinal environment of healthy individuals with soft stools

Journal of Bioscience and Bioengineering

Volumn 110, Issue 5, 2010, Pages 547-552

  Matsumoto, Kazumasa ^a   Takada, Toshihiko ^a   Shimizu, Kensuke ^a   Moriyama, Kaoru ^a   Kawakami, Koji ^a   Hirano, Koichi ^a   Kajimoto, Osami ^b,c   Nomoto, Koji ^a  

^a YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

^b Soiken Inc   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Fermented milk; Intestinal microbiota; Lactobacillus casei; Probiotics; Soft stool

Indexed keywords

FERMENTED MILK; INTESTINAL MICROBIOTA; LACTOBACILLUS CASEI; PROBIOTICS; SOFT STOOL;

FATTY ACIDS; ORGANIC ACIDS; WATER CONTENT;

BEVERAGES;

ACETIC ACID; BUTYRIC ACID; PLACEBO; PROBIOTIC AGENT; PROPIONIC ACID;

ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BIFIDOBACTERIUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFECATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FECES; HUMAN; INTESTINE FLORA; LACTOBACILLUS CASEI; MILK; RANDOMIZED CONTROLLED TRIAL; SOFT STOOL;

ADULT; ANIMALS; BIFIDOBACTERIUM; COLONY COUNT, MICROBIAL; CULTURED MILK PRODUCTS; DEFECATION; DOUBLE-BLIND METHOD; FECES; FOOD TECHNOLOGY; HUMANS; INTESTINES; LACTOBACILLUS CASEI; METAGENOME; PROBIOTICS;

BACTERIA (MICROORGANISMS); LACTOBACILLUS CASEI;

EID: 77957307220     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiosc.2010.05.016     Document Type: Article

References (24)

1. Ohya Y., Yoneda Y. Relationship between constipation and food intake and eating habits consciousness. Jpn. J. Nutr. 1995, 53:385-394. in Japanese.
2. Reid G. The importance of guidelines in the development and application of probiotics. Curr. Pharm. Des. 2005, 11:11-16.
3. Koebnick C., Wagner I., Leitzmann P., Stern U., Zunft H.F. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can. J. Gastroenterol. 2003, 17:655-659.
4. Matsumoto K., Takada T., Shimizu K., Kado Y., Kawakami K., Makino I., Yamaoka Y., Hirano K., Nishimura A., Kajimoto O., Nomoto K. The effects of probiotic milk product containing Lactobacillus casei strain Shirota on the defecation frequency and the intestinal microflora of sub-optimal health state volunteers: a randomized placebo-controlled cross-over study. Biosci. Microflora 2006, 25:39-48.
5. Spanhaak S., Havenaar R., Schaafsma G. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur. J. Clin. Nutr. 1998, 52:899-907.
6. Siitonen S., Vapaatalo H., Salminen S., Gordin A., Saxelin M., Wikberg R., Kirkkola A.L. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Annal. Med. 1990, 22:57-59.
7. Kajander K., Hatakka K., Poussa T., Farkkila M., Korpela R. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment. Pharmacol. Ther. 2005, 22:387-394.
8. Saggioro A. Probiotics in the treatment of irritable bowel syndrome. J. Clin. Gastroenterol. 2004, 38(6 Suppl):S104-S106.
9. Shirota M., Aso K., Iwabuchi A. Alteration of the constitution of the intestinal flora by oral administration of L. acidophilus strain Shirota to healthy infants. Jpn J. Bacteriol. 1966, 21:274-283.
10. Yuki T., Watanabe K., Mike A., Tagami Y., Tanaka R., Ohwaki M., Morotomi M. Survival of a probiotic, Lactobacillus casei strain Shirota, in the gastrointestinal tract: selective isolation from faeces and identification using monoclonal antibodies. Int. J. Food Microbiol. 1999, 48:51-55.
11. Shinozaki M., Fukudo S., Hongo M., Shimosegawa T., Sasaki D., Matsueda K., Harasawa S., Miura S., Mine T., Kaneko H., et al. High prevalence of irritable bowel syndrome in medical outpatients in Japan. J. Clin. Gastroenterol. 2008, 42:1010-1016.
12. Matsuki T., Watanabe K., Tanaka R., Oyaizu H. Rapid identification of human intestinal bifidobacteria by 16S rRNA-targeted species- and genus-specific primers. FEMS Microbiol. Lett. 1998, 167:113-121.
13. Matsuki T., Watanabe K., Fujimoto J., Miyamoto Y., Takada T., Matsumoto K., Oyaizu H., Tanaka R. Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl. Environ. Microbiol. 2002, 68:5445-5451.
14. Kikuchi H., Tajima T. Correlation between water-holding capacity of different types of cellulose in vitro and gastrointestinal retention time in vivo of rats. J. Sci. Food Agric. 1992, 60:139-146.
15. Birkett A.M., Jones G.P., Muir J.G. Simple high performance liquid chromatographic analysis of phenol and p-cresol in urine and feces. J. Chromatogr. B, Biomed. Appl. 1995, 674:187-191.
16. Vrese M., Marteau P.R. Probiotics and prebiotics: effects on diarrhea. J. Nutr. 2007, 137:803S-811S.
17. Shimoyama T., Hori S., Tamura K., Yamamura M., Tanaka M., Yamazaki K. Microflora of patients with stool abnormality. Bifidobacteria and Microflora 1984, 3:35-42.
18. Malinen E., Rinttila T., Kajander K., Matto J., Kassinen A., Krogius L., Saarela M., Korpela R., Palva A. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am. J. Gastroenterol. 2005, 100:373-382.
19. Vernia P., Latella G., Magliocca F.M., Mancuso G., Caprilli R. Seeking clues for a positive diagnosis of the irritable bowel syndrome. Eur. J. Clin. Invest. 1987, 17:189-193.
20. Flahaut S., Hartke A., Giard J.C., Boutibonnes A., Auffray Y. Relationship between stress response towards bile salts, acid and heat treatment in Enterococcus faecalis. FEMS Microbiol. Lett. 1996, 138:49-54.
21. Zotta T., Ricciardi A., Ciocia R., Parente E. Diversity of stress responses in diary thermophilic streptococci. Int. J. Food Microbiol. 2008, 124:34-42.
22. Gibson G.R., Wang X. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J. Appl. Bacteriol. 1994, 77:412-420.
23. Gilliland S.E. Health and nutritional benefits from lactic acid bacteria. FEMS Microbiol. Rev. 1990, 87:175-188.
24. Shioiri T., Yahagi K., Nakayama S., Asahara T., Yuki N., Kawakami K., Yamaoka Y., Sakai Y., Nomoto K., Totani M. The effects of a synbiotic fermented milk beverage containing Lactobacillus casei strain Shirota and transgalactosylated oligosaccharides on defecation frequency, intestinal microflora, organic acid concentrations, and putrefactive metabolites of sub-optimal health state volunteers: a randomized placebo-controlled cross-over study. Biosci. Microflora 2006, 25:137-146.